Idorsia Ltd banner

Idorsia Ltd
SIX:IDIA

Watchlist Manager
Idorsia Ltd Logo
Idorsia Ltd
SIX:IDIA
Watchlist
Price: 4.055 CHF -0.25%
Market Cap: CHf1B

Relative Value

The Relative Value of one IDIA stock under the Base Case scenario is hidden CHF. Compared to the current market price of 4.055 CHF, Idorsia Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IDIA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

IDIA Competitors Multiples
Idorsia Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Idorsia Ltd
SIX:IDIA
946.5m CHF 4.1 -8.1 -19.2 -16.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
411.5B USD 6.9 175.3 16.9 24
US
Amgen Inc
NASDAQ:AMGN
201.1B USD 5.5 26.1 14.9 14.9
US
Gilead Sciences Inc
NASDAQ:GILD
192.5B USD 6.5 22.6 15.4 15.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.8B USD 10.1 30.6 23.4 24.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.8B USD 5.8 18.6 14.2 16.2
AU
CSL Ltd
ASX:CSL
73.9B AUD 3.3 17.1 11.7 14.6
NL
argenx SE
XBRU:ARGX
43.4B EUR 14.3 33.6 57.8 59.4
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/S Multiple
Revenue Growth P/S to Growth
CH
Idorsia Ltd
SIX:IDIA
Average P/S: 3 058 675.4
4.1
39%
0.1
FR
Pharnext SCA
OTC:PNEXF
33 643 258.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.9
9%
0.8
US
Amgen Inc
NASDAQ:AMGN
5.5
2%
2.7
US
Gilead Sciences Inc
NASDAQ:GILD
6.5
5%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.1
10%
1
US
E
Epizyme Inc
F:EPE
2 094
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.8
9%
0.6
AU
CSL Ltd
ASX:CSL
3.3
5%
0.7
NL
argenx SE
XBRU:ARGX
14.3
49%
0.3
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
CH
Idorsia Ltd
SIX:IDIA
Average P/E: 46.3
Negative Multiple: -8.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
175.3
89%
2
US
Amgen Inc
NASDAQ:AMGN
26.1
18%
1.4
US
Gilead Sciences Inc
NASDAQ:GILD
22.6
14%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.6
17%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.6
13%
1.4
AU
CSL Ltd
ASX:CSL
17.1
11%
1.6
NL
argenx SE
XBRU:ARGX
33.6
42%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
Idorsia Ltd
SIX:IDIA
Average EV/EBITDA: 22
Negative Multiple: -19.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.9
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.9
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.4
18%
0.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.4
15%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.2
23%
0.6
AU
CSL Ltd
ASX:CSL
11.7
8%
1.5
NL
argenx SE
XBRU:ARGX
57.8
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CH
Idorsia Ltd
SIX:IDIA
Average EV/EBIT: 24.1
Negative Multiple: -16.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
24
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
14.9
2%
7.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.4
11%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.4
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
21%
0.8
AU
CSL Ltd
ASX:CSL
14.6
11%
1.3
NL
argenx SE
XBRU:ARGX
59.4
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A